Marginal Biofilm Distribution and Periodontal Response to Supragingival and Juxtagingival Aligner Designs
BIOFILM-ALIGN
1 other identifier
interventional
20
1 country
1
Brief Summary
- This prospective, longitudinal, within-person (split-mouth) clinical study evaluates the influence of two clear aligner trimming-line designs on marginal soft-tissue biofilm distribution and periodontal tissue response over a six-month period.
- Two trimming-line designs are compared. The supragingival design has a straight, horizontal edge that extends approximately 2 mm onto the marginal gingiva, resting in direct contact with the gingival surface but not entering the gingival sulcus. The juxtagingival design follows the scalloped contour of the gingival margin and terminates at the free gingival margin, without covering the gingiva and without entering the sulcus.
- Each participant receives both designs simultaneously, one per dental arch, and therefore serves as their own control. The assignment of each design to an arch is determined by the treating clinician according to the orthodontic treatment indications and is not randomized.
- The primary outcome is the percentage of sites with bleeding on probing per arch at six months. Secondary outcomes are bleeding on probing at three months, mean probing depth, maximum probing depth, and the Turesky-Quigley-Hein plaque index, with three exploratory photographic soft-tissue variables describing marginal gingival plaque presence, vestibular interdental papilla plaque presence, and the marginal demarcation pattern. Clinical and photographic assessments are performed at baseline (before aligner delivery), at three months, and at six months.
- All aligners are fabricated from a tri-layer clear aligner material (CA Pro, SCHEU-DENTAL GmbH, Iserlohn, Germany) by a single orthodontic laboratory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 6, 2026
CompletedFirst Posted
Study publicly available on registry
June 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
June 12, 2026
June 1, 2026
1.3 years
June 6, 2026
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bleeding on probing at 6 months (percentage of sites per arch)
Percentage of sites with bleeding on probing within each dental arch. Bleeding on probing is recorded as present or absent within approximately 10 to 15 seconds after gentle probing at six sites per tooth (mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, distolingual) using a calibrated periodontal probe. The percentage is calculated as the number of bleeding sites divided by the total number of scorable sites in the arch, multiplied by 100. The two arches within each participant are compared by trimming-line design. The primary endpoint is the within-person, between-arch difference at 6 months (T2), with baseline (T0) as the reference. The 3-month (T1) assessment is analyzed as a secondary, intermediate time point and does not contribute to the primary comparison.
Baseline (T0, before aligner delivery) and 6 months (T2)
Secondary Outcomes (4)
Bleeding on probing at 3 months (intermediate, percentage of sites per arch)
3 months (T1)
Mean probing depth (per arch)
Baseline (T0), 3 months (T1), and 6 months (T2)
Maximum probing depth (per arch)
Baseline (T0), 3 months (T1), and 6 months (T2)
Turesky-Quigley-Hein plaque index (per arch)
Baseline (T0), 3 months (T1), and 6 months (T2)
Other Outcomes (3)
Marginal Gingival Plaque Presence (MGPP%)
Baseline (T0), 3 months (T1), and 6 months (T2)
Vestibular Interdental Papilla Plaque Presence (VIPPP%)
Baseline (T0), 3 months (T1), and 6 months (T2)
Marginal Demarcation Pattern (MDP)
Baseline (T0), 3 months (T1), and 6 months (T2)
Study Arms (2)
Supragingival Trimming-Line Design
EXPERIMENTALDental arch fitted with a clear aligner trimmed with a supragingival straight-cut margin. The aligner edge extends approximately 2 mm onto the marginal gingiva, in direct contact with the gingival surface but without entering the gingival sulcus. Assigned to the arch with the greater planned intrusion; when planned intrusion is equal or absent on both arches, assignment follows a pre-specified alternating sequence in enrollment order.
Juxtagingival Festooned Trimming-Line Design
ACTIVE COMPARATORContralateral dental arch, within the same participant, fitted with a clear aligner trimmed with a juxtagingival festooned margin that follows the scalloped contour of the gingival margin and terminates at the free gingival margin, without covering the gingiva and without entering the sulcus. Assigned to the arch with the lesser or no planned intrusion.
Interventions
Clear aligner trimmed with a juxtagingival festooned margin following the scalloped gingival contour, terminating at the free gingival margin without covering the gingiva or entering the sulcus. Fabricated from CA Pro tri-layer thermoplastic material (SCHEU-DENTAL GmbH, Iserlohn, Germany; CE-marked) by Orto Performance Orthodontic Laboratory, Cluj-Napoca, Romania. The intervention under study is the trimming-line design, not the aligner material; material and thickness are identical to the comparator.
Clear aligner trimmed with a supragingival straight-cut margin extending approximately 2 mm onto the marginal gingiva, in direct contact with the gingiva but not entering the sulcus. Fabricated from CA Pro tri-layer thermoplastic material (SCHEU-DENTAL GmbH, Iserlohn, Germany; CE-marked) by Orto Performance Orthodontic Laboratory, Cluj-Napoca, Romania. The intervention under study is the trimming-line design, not the aligner material; material and thickness are identical to the comparator.
Eligibility Criteria
You may qualify if:
- Permanent dentition
- Adult patients
- Mild to moderate crowding not requiring extractions for orthodontic purposes
You may not qualify if:
- Mouth breathing (may influence the status of the marginal periodontium)
- Periodontal involvement (gingivitis or periodontitis)
- Presence of fixed prosthetic restorations with incorrect marginal adaptation
- Deficient oral hygiene
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aorys Clinic
Sibiu, Sibiu County, 550027, Romania
Related Publications (8)
Crego-Ruiz M, Jorba-Garcia A. Assessment of the periodontal health status and gingival recession during orthodontic treatment with clear aligners and fixed appliances: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023 Jul 1;28(4):e330-e340. doi: 10.4317/medoral.25760.
PMID: 36641738BACKGROUNDRusu EP, Lazar AP, Erhan BL, Bud E, Pacurar M, Lazar L. Clear Aligner Therapy and Marginal Edge Design: Clinical and Laboratory Evidence on Periodontal and Biological Outcomes-A Scoping Review. Dent J (Basel). 2026 Feb 24;14(3):130. doi: 10.3390/dj14030130.
PMID: 41892738BACKGROUNDFavero R, Libralato L, Balestro F, Volpato A, Favero L. Edge level of aligners and periodontal health: a clinical perspective study in young patients. Dental Press J Orthod. 2023 Apr 14;28(1):e2321124. doi: 10.1590/2177-6709.28.1.e2321124.oar. eCollection 2023.
PMID: 37075415BACKGROUNDEspana-Pamplona P, Bernes-Martinez L, Andres-Castello C, Bolas-Colvee B, Adobes-Martin M, Garcovich D. Changes in the Oral Microbiota with the Use of Aligners vs. Braces: A Systematic Review. J Clin Med. 2024 Dec 6;13(23):7435. doi: 10.3390/jcm13237435.
PMID: 39685893BACKGROUNDElshazly TM, Keilig L, Salvatori D, Chavanne P, Aldesoki M, Bourauel C. Effect of trimming line design and edge extension of orthodontic aligners on force transmission: An in vitro study. J Dent. 2022 Oct;125:104276. doi: 10.1016/j.jdent.2022.104276. Epub 2022 Aug 30.
PMID: 36055460BACKGROUNDLyu X, Cao X, Yan J, Zeng R, Tan J. Biomechanical effects of clear aligners with different thicknesses and gingival-margin morphology for appliance design optimization. Am J Orthod Dentofacial Orthop. 2023 Aug;164(2):239-252. doi: 10.1016/j.ajodo.2022.12.014. Epub 2023 Mar 21.
PMID: 36935221BACKGROUNDElshazly TM, Bourauel C, Chavanne P, Elattar H, Keilig L. Numerical biomechanical finite element analysis of different trimming line designs of orthodontic aligners: An in silico study. J World Fed Orthod. 2024 Apr;13(2):65-71. doi: 10.1016/j.ejwf.2024.01.001. Epub 2024 Feb 23.
PMID: 38395726BACKGROUNDRouzi M, Zhang X, Jiang Q, Long H, Lai W, Li X. Impact of Clear Aligners on Oral Health and Oral Microbiome During Orthodontic Treatment. Int Dent J. 2023 Oct;73(5):603-611. doi: 10.1016/j.identj.2023.03.012. Epub 2023 Apr 25.
PMID: 37105789BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
LUMINITA LAZAR, PhD, Professor
George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 540139 Targu Mures, Romania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor masking. Clinical periodontal assessments (probing depth and bleeding on probing) are performed by a calibrated examiner blinded to the trimming-line allocation; at each visit the participant removes both aligners before the examiner enters, and the examiner has no access to treatment plans or allocation records. Periodontal charting is performed on undisclosed tissue, before the disclosing agent and photography; the plaque-based marginal demarcation has no clinically visible tissue component and is therefore not perceptible at the time of clinical assessment. Photographic outcomes are scored independently by two examiners blinded to allocation, from de-identified images coded with random identifiers and presented in randomized order; inter-examiner agreement is assessed using the Cohen kappa coefficient. The treating clinician, who assigns the designs, is not an outcome assessor.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 6, 2026
First Posted
June 11, 2026
Study Start
March 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
June 12, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available, as the small single-site cohort (20 participants) cannot be fully de-identified without risk to participant confidentiality. De-identified data may be made available from the principal investigator on reasonable academic request, subject to an appropriate data-sharing agreement and ethics approval. Aggregate results will be reported in the doctoral thesis and in peer-reviewed publication.